 | • レポートコード：MRC2-11QY06018 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は女性用避妊薬のグローバル市場について調査・分析したレポートです。種類別（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別女性用避妊薬の競争状況、市場シェア ・世界の女性用避妊薬市場：種類別市場規模 2015年-2020年（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他） ・世界の女性用避妊薬市場：種類別市場規模予測 2021年-2026年（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他） ・世界の女性用避妊薬市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の女性用避妊薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の女性用避妊薬市場分析：米国、カナダ ・ヨーロッパの女性用避妊薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの女性用避妊薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の女性用避妊薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの女性用避妊薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Female Contraception Drug Market
The global Female Contraception Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Female Contraception Drug Scope and Market Size
Female Contraception Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraception Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Female Contraception Drug market is segmented into
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Segment by Application, the Female Contraception Drug market is segmented into
Clinic
Hospital
Homecare
Regional and Country-level Analysis
The Female Contraception Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Female Contraception Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Female Contraception Drug Market Share Analysis
Female Contraception Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Female Contraception Drug business, the date to enter into the Female Contraception Drug market, Female Contraception Drug product introduction, recent developments, etc.
The major vendors covered:
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
1 Study Coverage
1.1 Female Contraception Drug Product Introduction
1.2 Market Segments
1.3 Key Female Contraception Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Female Contraception Drug Market Size Growth Rate by Type
1.4.2 AG-890
1.4.3 Amphora
1.4.4 BAY-1007626
1.4.5 Drospirenone
1.4.6 Others
1.5 Market by Application
1.5.1 Global Female Contraception Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Female Contraception Drug Market Size, Estimates and Forecasts
2.1.1 Global Female Contraception Drug Revenue 2015-2026
2.1.2 Global Female Contraception Drug Sales 2015-2026
2.2 Global Female Contraception Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Female Contraception Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Female Contraception Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Female Contraception Drug Competitor Landscape by Players
3.1 Female Contraception Drug Sales by Manufacturers
3.1.1 Female Contraception Drug Sales by Manufacturers (2015-2020)
3.1.2 Female Contraception Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Female Contraception Drug Revenue by Manufacturers
3.2.1 Female Contraception Drug Revenue by Manufacturers (2015-2020)
3.2.2 Female Contraception Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Female Contraception Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Female Contraception Drug Revenue in 2019
3.2.5 Global Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Female Contraception Drug Price by Manufacturers
3.4 Female Contraception Drug Manufacturing Base Distribution, Product Types
3.4.1 Female Contraception Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Female Contraception Drug Product Type
3.4.3 Date of International Manufacturers Enter into Female Contraception Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Female Contraception Drug Market Size by Type (2015-2020)
4.1.1 Global Female Contraception Drug Sales by Type (2015-2020)
4.1.2 Global Female Contraception Drug Revenue by Type (2015-2020)
4.1.3 Female Contraception Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Female Contraception Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Female Contraception Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Female Contraception Drug Revenue Forecast by Type (2021-2026)
4.2.3 Female Contraception Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Female Contraception Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Female Contraception Drug Market Size by Application (2015-2020)
5.1.1 Global Female Contraception Drug Sales by Application (2015-2020)
5.1.2 Global Female Contraception Drug Revenue by Application (2015-2020)
5.1.3 Female Contraception Drug Price by Application (2015-2020)
5.2 Female Contraception Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Female Contraception Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Female Contraception Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Female Contraception Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Female Contraception Drug by Country
6.1.1 North America Female Contraception Drug Sales by Country
6.1.2 North America Female Contraception Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Female Contraception Drug Market Facts & Figures by Type
6.3 North America Female Contraception Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Female Contraception Drug by Country
7.1.1 Europe Female Contraception Drug Sales by Country
7.1.2 Europe Female Contraception Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Female Contraception Drug Market Facts & Figures by Type
7.3 Europe Female Contraception Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Female Contraception Drug by Region
8.1.1 Asia Pacific Female Contraception Drug Sales by Region
8.1.2 Asia Pacific Female Contraception Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Female Contraception Drug Market Facts & Figures by Type
8.3 Asia Pacific Female Contraception Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Female Contraception Drug by Country
9.1.1 Latin America Female Contraception Drug Sales by Country
9.1.2 Latin America Female Contraception Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Female Contraception Drug Market Facts & Figures by Type
9.3 Central & South America Female Contraception Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Female Contraception Drug by Country
10.1.1 Middle East and Africa Female Contraception Drug Sales by Country
10.1.2 Middle East and Africa Female Contraception Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Female Contraception Drug Market Facts & Figures by Type
10.3 Middle East and Africa Female Contraception Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Female Contraception Drug Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.2 Agile Therapeutics Inc
11.2.1 Agile Therapeutics Inc Corporation Information
11.2.2 Agile Therapeutics Inc Description and Business Overview
11.2.3 Agile Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Agile Therapeutics Inc Female Contraception Drug Products Offered
11.2.5 Agile Therapeutics Inc Related Developments
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Description and Business Overview
11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer AG Female Contraception Drug Products Offered
11.3.5 Bayer AG Related Developments
11.4 Evofem Inc
11.4.1 Evofem Inc Corporation Information
11.4.2 Evofem Inc Description and Business Overview
11.4.3 Evofem Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Evofem Inc Female Contraception Drug Products Offered
11.4.5 Evofem Inc Related Developments
11.5 Hervana Ltd
11.5.1 Hervana Ltd Corporation Information
11.5.2 Hervana Ltd Description and Business Overview
11.5.3 Hervana Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hervana Ltd Female Contraception Drug Products Offered
11.5.5 Hervana Ltd Related Developments
11.6 Mithra Pharmaceuticals SA
11.6.1 Mithra Pharmaceuticals SA Corporation Information
11.6.2 Mithra Pharmaceuticals SA Description and Business Overview
11.6.3 Mithra Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Products Offered
11.6.5 Mithra Pharmaceuticals SA Related Developments
11.7 Orbis Biosciences Inc
11.7.1 Orbis Biosciences Inc Corporation Information
11.7.2 Orbis Biosciences Inc Description and Business Overview
11.7.3 Orbis Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Orbis Biosciences Inc Female Contraception Drug Products Offered
11.7.5 Orbis Biosciences Inc Related Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Products Offered
11.8.5 Teva Pharmaceutical Industries Ltd Related Developments
11.9 Viramal Ltd
11.9.1 Viramal Ltd Corporation Information
11.9.2 Viramal Ltd Description and Business Overview
11.9.3 Viramal Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Viramal Ltd Female Contraception Drug Products Offered
11.9.5 Viramal Ltd Related Developments
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Female Contraception Drug Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Female Contraception Drug Market Estimates and Projections by Region
12.1.1 Global Female Contraception Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Female Contraception Drug Revenue Forecast by Regions 2021-2026
12.2 North America Female Contraception Drug Market Size Forecast (2021-2026)
12.2.1 North America: Female Contraception Drug Sales Forecast (2021-2026)
12.2.2 North America: Female Contraception Drug Revenue Forecast (2021-2026)
12.2.3 North America: Female Contraception Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Female Contraception Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Female Contraception Drug Sales Forecast (2021-2026)
12.3.2 Europe: Female Contraception Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Female Contraception Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Female Contraception Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Female Contraception Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Female Contraception Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Female Contraception Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Female Contraception Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Female Contraception Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Female Contraception Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Female Contraception Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Female Contraception Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Female Contraception Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Female Contraception Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Female Contraception Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Female Contraception Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Female Contraception Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Female Contraception Drug Market Segments
Table 2. Ranking of Global Top Female Contraception Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Female Contraception Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AG-890
Table 5. Major Manufacturers of Amphora
Table 6. Major Manufacturers of BAY-1007626
Table 7. Major Manufacturers of Drospirenone
Table 8. Major Manufacturers of Others
Table 9. Global Female Contraception Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Female Contraception Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Female Contraception Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Female Contraception Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Female Contraception Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Female Contraception Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Female Contraception Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Female Contraception Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Female Contraception Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraception Drug as of 2019)
Table 18. Female Contraception Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Female Contraception Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Female Contraception Drug Price (2015-2020) (USD/Pcs)
Table 21. Female Contraception Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Female Contraception Drug Product Type
Table 23. Date of International Manufacturers Enter into Female Contraception Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Female Contraception Drug Sales Share by Type (2015-2020)
Table 27. Global Female Contraception Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Female Contraception Drug Revenue Share by Type (2015-2020)
Table 29. Female Contraception Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Female Contraception Drug Sales Share by Application (2015-2020)
Table 32. North America Female Contraception Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Female Contraception Drug Sales Market Share by Country (2015-2020)
Table 34. North America Female Contraception Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Female Contraception Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Female Contraception Drug Sales Market Share by Type (2015-2020)
Table 38. North America Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Female Contraception Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Female Contraception Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Female Contraception Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Female Contraception Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Female Contraception Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Female Contraception Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Female Contraception Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Female Contraception Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Female Contraception Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Female Contraception Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Female Contraception Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Female Contraception Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Female Contraception Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Female Contraception Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Female Contraception Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Female Contraception Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Female Contraception Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Female Contraception Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Female Contraception Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Female Contraception Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Female Contraception Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Female Contraception Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Female Contraception Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Female Contraception Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Female Contraception Drug Sales Market Share by Application (2015-2020)
Table 72. Addex Therapeutics Ltd Corporation Information
Table 73. Addex Therapeutics Ltd Description and Major Businesses
Table 74. Addex Therapeutics Ltd Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Addex Therapeutics Ltd Product
Table 76. Addex Therapeutics Ltd Recent Development
Table 77. Agile Therapeutics Inc Corporation Information
Table 78. Agile Therapeutics Inc Description and Major Businesses
Table 79. Agile Therapeutics Inc Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Agile Therapeutics Inc Product
Table 81. Agile Therapeutics Inc Recent Development
Table 82. Bayer AG Corporation Information
Table 83. Bayer AG Description and Major Businesses
Table 84. Bayer AG Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bayer AG Product
Table 86. Bayer AG Recent Development
Table 87. Evofem Inc Corporation Information
Table 88. Evofem Inc Description and Major Businesses
Table 89. Evofem Inc Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Evofem Inc Product
Table 91. Evofem Inc Recent Development
Table 92. Hervana Ltd Corporation Information
Table 93. Hervana Ltd Description and Major Businesses
Table 94. Hervana Ltd Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Hervana Ltd Product
Table 96. Hervana Ltd Recent Development
Table 97. Mithra Pharmaceuticals SA Corporation Information
Table 98. Mithra Pharmaceuticals SA Description and Major Businesses
Table 99. Mithra Pharmaceuticals SA Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Mithra Pharmaceuticals SA Product
Table 101. Mithra Pharmaceuticals SA Recent Development
Table 102. Orbis Biosciences Inc Corporation Information
Table 103. Orbis Biosciences Inc Description and Major Businesses
Table 104. Orbis Biosciences Inc Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Orbis Biosciences Inc Product
Table 106. Orbis Biosciences Inc Recent Development
Table 107. Teva Pharmaceutical Industries Ltd Corporation Information
Table 108. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 109. Teva Pharmaceutical Industries Ltd Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Teva Pharmaceutical Industries Ltd Product
Table 111. Teva Pharmaceutical Industries Ltd Recent Development
Table 112. Viramal Ltd Corporation Information
Table 113. Viramal Ltd Description and Major Businesses
Table 114. Viramal Ltd Female Contraception Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Viramal Ltd Product
Table 116. Viramal Ltd Recent Development
Table 117. Global Female Contraception Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Female Contraception Drug Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Female Contraception Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Female Contraception Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Female Contraception Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Female Contraception Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Female Contraception Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Female Contraception Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Female Contraception Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Female Contraception Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Female Contraception Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Female Contraception Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Female Contraception Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Female Contraception Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Female Contraception Drug Players
Table 135. Female Contraception Drug Customers List
Table 136. Female Contraception Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Contraception Drug Product Picture
Figure 2. Global Female Contraception Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AG-890 Product Picture
Figure 4. Amphora Product Picture
Figure 5. BAY-1007626 Product Picture
Figure 6. Drospirenone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Female Contraception Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Female Contraception Drug Report Years Considered
Figure 13. Global Female Contraception Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Female Contraception Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Female Contraception Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Female Contraception Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Female Contraception Drug Sales Market Share by Region in 2019
Figure 18. Global Female Contraception Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Female Contraception Drug Revenue Market Share by Region in 2019
Figure 20. Global Female Contraception Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Female Contraception Drug Revenue in 2019
Figure 22. Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Female Contraception Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Female Contraception Drug Sales Market Share by Type in 2019
Figure 25. Global Female Contraception Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Female Contraception Drug Revenue Market Share by Type in 2019
Figure 27. Global Female Contraception Drug Market Share by Price Range (2015-2020)
Figure 28. Global Female Contraception Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Female Contraception Drug Sales Market Share by Application in 2019
Figure 30. Global Female Contraception Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Female Contraception Drug Revenue Market Share by Application in 2019
Figure 32. North America Female Contraception Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Female Contraception Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Female Contraception Drug Sales Market Share by Country in 2019
Figure 35. North America Female Contraception Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Female Contraception Drug Market Share by Type in 2019
Figure 41. North America Female Contraception Drug Market Share by Application in 2019
Figure 42. Europe Female Contraception Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Female Contraception Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Female Contraception Drug Sales Market Share by Country in 2019
Figure 45. Europe Female Contraception Drug Revenue Market Share by Country in 2019
Figure 46. Germany Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Female Contraception Drug Market Share by Type in 2019
Figure 57. Europe Female Contraception Drug Market Share by Application in 2019
Figure 58. Asia Pacific Female Contraception Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Female Contraception Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Female Contraception Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Female Contraception Drug Revenue Market Share by Region in 2019
Figure 62. China Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Female Contraception Drug Market Share by Type in 2019
Figure 85. Asia Pacific Female Contraception Drug Market Share by Application in 2019
Figure 86. Latin America Female Contraception Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Female Contraception Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Female Contraception Drug Sales Market Share by Country in 2019
Figure 89. Latin America Female Contraception Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Female Contraception Drug Market Share by Type in 2019
Figure 97. Latin America Female Contraception Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Female Contraception Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Female Contraception Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Female Contraception Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Female Contraception Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Female Contraception Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Female Contraception Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Female Contraception Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Female Contraception Drug Market Share by Application in 2019
Figure 110. North America Female Contraception Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Female Contraception Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Female Contraception Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Female Contraception Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Female Contraception Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Female Contraception Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Female Contraception Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Female Contraception Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Female Contraception Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Female Contraception Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Female …- 女性用不妊症診断・治療の世界市場（～2026年） Female infertility refers to infertility in female humans. The major factors that are augmenting the growth of the female infertility market are changing life style and increasing IVF market. Furthermore, rising trend of surrogacy, growing infertility rate among female, new technologies to avoid mul…
- 女性用コンドームの世界市場（～2026年） A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). The online stores will be the fastest-growing segment and will continue to maintain its lea…
- 女性用性玩具の世界市場（～2026年） A sex toy refers to an external object that is used to stimulate and increase the sexual pleasure of users, thereby leading to sexual satisfaction. The online segment accounted for the major shares and dominated this market. Factors such as the improved accessibility and variety based on price to co…
- 女性用フレグランスの世界市場（～2026年） Fragrance, certainly one of the most important and appealing personal care accessories, is a favorite among ladies across the globe. Extensive advertising is expected to remain one of the key drivers to the global female fragrance market. Increasing celebrity endorsements for perfumes will continue …